Cascade of Costs Could Push New Gene Therapy Above $1 Million Per Patient
The costs of using a new class of cancer treatments include far more than the drug鈥檚 sticker price.
Health Industry
2,501-2,520 of 4,028 results
-
-
Anthem Eases Up On Premium Hikes After State Scrutiny
After regulators questioned Anthem鈥檚 forecast for medical costs, the company agreed to reduce rate hikes on its individual and small-business health plans next year, saving customers an estimated $114 million.
By Chad Terhune -
In Oregon, End-of-Life Wishes Are Just A Click Away
A new link creates two-way access to the state registry that documents the type of medical care sick and frail patients want 鈥 or refuse.
-
New Law Challenges ‘Evils’ Of Pharma Profits, California Governor Claims
Gov. Jerry Brown signed the measure, which takes effect next year and will require drug companies to publicly justify big price increases.
-
Training New Doctors Right Where They鈥檙e Needed
Eight teaching centers in California aim to train and retain doctors in medically underserved areas such as California鈥檚 Central Valley. They are among 57 such institutions across the country that may soon receive a boost in funding from Congress.
-
Eyes Fixed On California As Governor Ponders Inking Drug Price Transparency Bill
"If it gets signed by this governor, it's going to send shock waves throughout the country,鈥 one legislator says. Pharma has spent $16.8 million lobbying against this bill and other drug laws in California.
-
Las Vegas Faced a Massacre. Did It Have Enough Trauma Centers?
Hospitals view adding trauma care as a potential profit tool, but experts say having more centers does not necessarily improve the system鈥檚 ability to respond to a mass casualty event.
By Julie Appleby and Phil Galewitz -
Heart Device Failure: Medicare Spent $1.5B Over 10 Years To Replace Defective Implants
The inspector general at Health and Human Services says defective pacemakers or defibrillators had to be replaced from 2005 through 2014, costing Medicare $1.5 billion.
By Fred Schulte and Christina Jewett -
Latest Scandal Too Much For HHS Secretary Tom Price. He’s Out.
Tom Price resigned from running the Department of Health and Human Services after a series of news stories detailing how he tallied more than $400,000 in private plane travel paid for by taxpayers.听
By Julie Rovner -
For Some Refugees, Women’s Health Care Is A Culture Shock
Refugee women from conservative Muslim countries can be shocked by some U.S. medical conventions 鈥 like trusting a male doctor to care for them.
By Sarah Varney -
Right After Trump Blamed High Drug Prices On Campaign Cash, Drugmakers Gave More
At a political rally in March, President Donald Trump said drug prices are 鈥渙utrageous鈥 and blamed campaign contributions. Drugmakers funneled nearly $280,000 to Congress the very next day.
By Sydney Lupkin and Elizabeth Lucas -
Nowhere To Go: Young People With Severe Autism Languish In Hospitals
Some teens and young adults are spending weeks or even months in retrofitted emergency rooms 鈥 even in mesh-covered tents 鈥 until specialized care can be found. 鈥業t鈥檚 a huge problem,鈥 one doctor says.
-
Need An MRI? Anthem Directs Most Outpatients To Independent Centers
The insurer says hospital-based imaging services are too expensive and the independent facilities provide high-quality care.
-
News Analysis
Everyone Says We Must Control Exorbitant Drug Prices. So, Why Don鈥檛 We?
Any momentum to address prescription drug costs has been lost amid rancorous debates over replacing Obamacare and stalled by roadblocks erected via lobbying and industry cash.
By Jay Hancock -
To Wage War On Superbugs, FDA Clears Way For Scope With A Disposable Piece
Agency says a removable cap will lower the risk of antibiotic resistant infections but some experts see it as a modest step in curbing the sort of deadly outbreaks that occurred a few years ago.
By Chad Terhune -
High On Drugs? Anthem Cites Soaring Drug Costs To Justify 35% Rate Hike in California
The company鈥檚 drug spending prediction, far above other insurers in the individual market, has experts scratching their heads. Anthem cites market volatility.
听By Chad Terhune -
Open Your Mouth And Say Goo-Goo: Dentists Treating Ever-Younger Patients
A shift in dental guidelines encourages first dental visits for infants as young as 6 months, or when the first baby teeth emerge. That makes some dentists uncomfortable.
-
As Care Shifts From Hospital To Home, Guarding Against Infection Falls To Families
Despite a lack of medical training, relatives increasingly are assigned complex, risky medical tasks at home, such as maintaining catheters. If done incorrectly, blood clots, infections, even death can result.
-
Trump’s Deadline On ‘Dreamers’ Reverberates Through Health Industries
From medical students to home health aides, the loss of DACA could deal a blow to the health care workforce, industry leaders suggest.
-
The Orphan Drug Machine
Without Price Breaks, Rural Hospitals Struggle To Stock Costly, Lifesaving Drugs
A federal drug program blocks rural hospitals from getting discounts on rare-disease drugs, forcing staff to cut back on supplies of lifesaving medicines.